Skip to main content

Publications

featured publications

  • Requirements for Translation in Clinical Trials of Aromatherapy: The Case of the Essential Oil of Bergamot (BEO) for Management of Agitation in Severe Dementia.

    Current pharmaceutical design

    Authors: Damiana Scuteri, Shinobu Sakurada, Tsukasa Sakurada, Paolo Tonin, Giacinto Bagetta, Pierluigi Nicotera, Maria Tiziana Corasaniti

  • New trends in pharmacological control of neuropsychiatric symptoms of dementia.

    Current opinion in pharmacology

    Authors: Damiana Scuteri, Maria Tiziana Corasaniti, Paolo Tonin, Pierluigi Nicotera, Giacinto Bagetta

  • Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double-blind, placebo-controlled trial to assess the efficacy of furocoumarin-free bergamot loaded in a nanotechnology-based delivery system of the …

    Phytotherapy research : PTR

    Authors: Damiana Scuteri, Giorgio Sandrini, Stefano Tamburin, Maria Tiziana Corasaniti, Pierluigi Nicotera, Paolo Tonin, Giacinto Bagetta

  • The histone code in dementia: Transcriptional and chromatin plasticity fades away.

    Current opinion in pharmacology

    Authors: Daniele Bano, Paolo Salomoni, Dan Ehninger, Pierluigi Nicotera

  • Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy.

    The journal of headache and pain

    Authors: Damiana Scuteri, Maria Tiziana Corasaniti, Paolo Tonin, Pierluigi Nicotera, Giacinto Bagetta

  • Comparative analysis of CI- and CIV-containing respiratory supercomplexes at single-cell resolution.

    Cell reports methods

    Authors: Fabio Bertan, Lena Wischhof, Enzo Scifo, Mihaela Guranda, Joshua Jackson, Anaïs Marsal-Cots, Antonia Piazzesi, Miriam Stork, Michael Peitz, Jochen Herbert Martin Prehn, Dan Ehninger, Pierluigi Nicotera, Daniele Bano

  • Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia.

    Pharmaceutics

    Authors: Damiana Scuteri, Roberta Cassano, Sonia Trombino, Rossella Russo, Hirokazu Mizoguchi, Chizuko Watanabe, Kengo Hamamura, Soh Katsuyama, Takaaki Komatsu, Luigi Antonio Morrone, Laura Rombolà, Annagrazia Adornetto, Annarita S Laganà, Maria Tiziana Corasaniti, Paolo Tonin, Shinobu Sakurada, Tsukasa Sakurada, Pierluigi Nicotera, Giacinto Bagetta

  • Correction: Loss of Ryanodine Receptor 2 impairs neuronal activity-dependent remodeling of dendritic spines and triggers compensatory neuronal hyperexcitability.

    Cell death and differentiation

    Authors: Fabio Bertan, Lena Wischhof, Liudmila Sosulina, Manuel Mittag, Dennis Dalügge, Alessandra Fornarelli, Fabrizio Gardoni, Elena Marcello, Monica Di Luca, Martin Fuhrmann, Stefan Remy, Daniele Bano, Pierluigi Nicotera

  • On Sten Orrenius (1937-2020).

    Cell death and differentiation

    Authors: Boris Zhivotovsky, Pierluigi Nicotera

  • Loss of Ryanodine Receptor 2 impairs neuronal activity-dependent remodeling of dendritic spines and triggers compensatory neuronal hyperexcitability.

    Cell death and differentiation

    Authors: Fabio Bertan, Lena Wischhof, Liudmila Sosulina, Manuel Mittag, Dennis Dalügge, Alessandra Fornarelli, Fabrizio Gardoni, Elena Marcello, Monica Di Luca, Martin Fuhrmann, Stefan Remy, Daniele Bano, Pierluigi Nicotera